Nitric oxide and septic shock

JAMA

Volumn 275, Issue 15, 1996, Pages 1192-1196

  Cobb, J Perren ^a,b   Danner, Robert L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; CASE REPORT; ENDOTHELIUM CELL; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MULTIPLE ORGAN FAILURE; OXYGEN TRANSPORT; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEPTIC SHOCK;

EID: 0029864356     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.15.1192     Document Type: Article

References (59)

1. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med. 1994;120: 771-783.
2. Nathan CF, Stuehr DJ. Does endothelium-derived nitric oxide have a role in cytokine-induced hypotension? J Natl Cancer Inst. 1990;82:726-728.
3. Cobb JP, Cunnion RE, Danner RL. Nitric oxide as a target for therapy in septic shock. Crit Care Med. 1993;21:1261-1263.
4. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064.
5. Nathan C, Xie Q-w. Nitric oxide synthases: roles, tolls, controls. Cell. 1994;78:915-918.
6. G- methylarginine. Biochem Biophys Res Commun. 1990;170:96-103.
7. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 1991;214:621-626.
8. Ochoa JB, Curti B, Peitzman AB, et al. Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes. J Natl Cancer Inst. 1992;84:864-867.
9. Hibbs JB Jr, Westenfelder C, Taintor R, et al. Evidence for cytokine-inducible nitric oxide synthase from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest. 1992;89:867-877.
10. G-methyl- L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun. 1990;172:1132-1138.
11. G- methyl-L-arginine inhibits tumor necrosis factor- induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A. 1990;87:3629-3632.
12. Hollenberg SM, Cunnion RE, Zimmerberg J. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to oatecholamines in septic rats. Am J Physiol. 1993;264:H660-H663.
13. Petros A, Bennett D, Valance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 1991;338:1557-1558.
14. Geroulanos S, Schilling J, Cakmakci M, Jung HH, Largiader F. Inhibition of NO synthesis in septic shock. Lancet. 1992;339:435.
15. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
16. Van Dervort AL, Yan L, Madara PJ, et al. Nitric oxide regulates endotoxin-induced TNF-α production by human neutrophils. J Immunol. 1994; 152:4102-4109.
17. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adherence. Proc Natl Acad Sci U S A. 1991;88:4651-4655.
18. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78:931-936.
19. MacNaul KL, Hutchinson NI. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun. 1993;196:1330-1334.
20. Danner RL, Cobb JP, Van Dervort AL. Nitric oxide as a mediator of hypotension and inflammation in sepsis. In: Fink MP, Payen D, eds. Role of Nitric Oxide in Sepsis and ARDS. New York, NY: Springer-Verlag NY Inc; 1995;24:155-180.
21. G-monomethyl-L- arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun. 1991;178:1135-1140.
22. Perrella MA, Hildebrand KB Jr, Margulies KB, Burnett JC Jr. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am J Physiol. 1991;261:R323-R328.
23. ω-amino- L-arginine. J Natl Cancer Inst. 1992;84:1008-1016.
24. Preiser JC, Zhang H, Wachel D, Boeynaems JM, Buurman W, Vincent J-L. Is endotoxin-induced hypotension related to nitric oxide formation. Eur Surg Res. 1994;36:10-18.
25. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res. 1994;75:1086-1095.
26. ω- amino-L-arginine, an inhibitor or rutne oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med. 1992;176:1175-1182.
27. Cobb JP, Natanson C, Quezado ZMN, et al. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol. 1995; 268:H1634-H1642.
28. G-methyl-L- arginine in chronically instrumented conscious dogs. J Appl Physiol. 1994;77:471-475.
29. Lorente JA, Landin L, Renes E, et al. Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med. 1993;21:759-767.
30. Landin L, Lorente JA, Renes E, Canas P, Jorge P, Liste D. Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest. 1994;106:250-256.
31. Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA Jr. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg. 1994;129:149-155.
32. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993;11: 1375-1380.
33. Statman R, Cheng W, Cunningham JN, et al. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J Surg Res. 1994;57:93-98.
34. Meyer J, Lentz CW, Stothert JC, Traber LD, Herndon DN, Traber DL. Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med. 1994;22:306-312.
35. Meyer J, Traber LD, Nelson S, et al. Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol. 1992;73:324-328.
36. Klemm P, Thiemermann C, Winklmaier G, Martorana PA, Henning R. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock. Br J Pharmacol. 1995;114:363-368.
37. Kilbourn RG, Owen-Schaub LB, Cromeens DM, et al. NG-methyl-L-arginne, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs. J Appl Physiol 1994;76:1130-1137.
38. ω-methyl-L-arginine (NMA) alone or in combination with epinephrine (EPI) in a canine peritonitis model of septic shock. In: Program and abstracts of the 24th annual meeting of the French Intensive Care Society, January 18, 1996; Paris, France. Abstract 039.
39. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 1994;28:34-39
40. Lorente JA, Landin L, de Pablo R. Renes E, Liste D. L-arginine pathway in the sepsis syndrome. Crit Care Med. 1993;21:1287-1295.
41. G-methyl-L-arginine in cancer patients with shock. Endothelium. 1995;3:S15. Abstract 57.
42. G-methyl-L-arginine, and inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. Crit Care Med. 1995;3:1018-1023.
43. Teale DM, Atkinson AM. Inhibition of nitric oxide synthase improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother. 1992;30:839-842.
44. Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet. 1991;338:1555-1557.
45. G-mono- methyl-L-arginine HCl (L-NMMA: 546C88) improves survival in a conscious instrumented mouse model of endotoxin shock. Endothelium. 1995;3: S116. Abstract 460.
46. Evans T, Carpenter A, Sliva A, Cohen J. Inhibition of nitric oxide synthase in experimental gram- negative sepsis. J Infect Dis. 1994;169:343-349.
47. Yan L, Vandivier RW, Sufredini AF, Dannr RL. Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity. J Immunol. 1994;153:1825-1834.
48. MacMicking JD, Nathan C, Hom G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995;81:641-650.
49. Wei X, Charles IG, Smith A, et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 1995;375:408-411.
50. Hutcheson IR, Whittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol. 1990;101:815-820.
51. Spain DA, Wilson MA, Garrison RN. Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery. 1994;116:322-331.
52. Minnard EA, Shou J, Naama H, Ceeh A, Gallagher H, Daly JM. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg. 1994;129:142-148.
53. G-nitro-L-arginine methyl ester, and inhibitor of nitric oxide synthesis, in sheep. Anesth Analg. 1993;77:1215-1221.
54. G-monomethyl- L-arginine between conscious and anesthetized rats. Jpn J Pharmacol. 1991;56:245-248.
55. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A. 1995;92:10688-10692.
56. Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sd U S A. 1993;90:3491-3495.
57. Harbrecht BG, Billiar TR, Stadler J, et al. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med. 1992;20:1568-1574.
58. G-nitro-L-arginine infusion in porcine endotoxin shock. Crit Care Med. 1995;3:909-918.
59. Morris SM Jr, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol. 1994;266:E829-E839.